Young people more likely to be affected by rare vaccine clots, MHRA says

Vials of the Oxford/AstraZeneca coronavirus vaccine (Yui Mok/PA)
Vials of the Oxford/AstraZeneca coronavirus vaccine (Yui Mok/PA)